Lataa...
Cholesterol lowering for secondary prevention: What statin dose should we use?
Over the past decade, 17 large placebo-controlled trials have established that statin therapy lowers LDL cholesterol and prevents cardiovascular events and death in patients with coronary disease or at high risk for atherosclerotic events. Nine trials of higher dose vs. lower dose statins (reporting...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2007
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2291306/ https://ncbi.nlm.nih.gov/pubmed/18078013 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|